SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 156 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.55 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $373,576 | +28.0% | 389,142 | 0.0% | 0.00% | – |
Q1 2023 | $291,857 | +103.5% | 389,142 | 0.0% | 0.00% | – |
Q4 2022 | $143,399 | -14.1% | 389,142 | 0.0% | 0.00% | – |
Q3 2022 | $167,000 | -45.1% | 389,142 | 0.0% | 0.00% | -100.0% |
Q2 2022 | $304,000 | +30300.0% | 389,142 | +62162.7% | 0.00% | – |
Q3 2021 | $1,000 | -75.0% | 625 | -38.2% | 0.00% | – |
Q2 2021 | $4,000 | +100.0% | 1,011 | +1.3% | 0.00% | – |
Q1 2020 | $2,000 | – | 998 | +1591.5% | 0.00% | – |
Q4 2019 | $0 | -100.0% | 59 | -80.4% | 0.00% | – |
Q3 2019 | $2,000 | -33.3% | 301 | +1.0% | 0.00% | – |
Q2 2019 | $3,000 | +200.0% | 298 | +144.3% | 0.00% | – |
Q1 2019 | $1,000 | -90.9% | 122 | -90.4% | 0.00% | – |
Q4 2018 | $11,000 | -63.3% | 1,273 | -29.7% | 0.00% | – |
Q3 2018 | $30,000 | -54.5% | 1,810 | -42.7% | 0.00% | – |
Q2 2018 | $66,000 | +73.7% | 3,161 | +33.9% | 0.00% | – |
Q1 2018 | $38,000 | – | 2,361 | +5032.6% | 0.00% | – |
Q2 2016 | $0 | -100.0% | 46 | -93.0% | 0.00% | – |
Q2 2013 | $5,000 | – | 661 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 787,973 | $615,000 | 0.77% |
CM Management, LLC | 600,000 | $468,000 | 0.50% |
ARMISTICE CAPITAL, LLC | 17,100,000 | $13,338,000 | 0.23% |
Sargent Investment Group, LLC | 614,600 | $479,000 | 0.15% |
Ergoteles LLC | 744,275 | $581,000 | 0.02% |
Sonora Investment Management Group, LLC | 103,000 | $80,000 | 0.01% |
CAXTON ASSOCIATES LP | 107,135 | $84,000 | 0.01% |
MCDONALD PARTNERS LLC | 42,570 | $33,000 | 0.01% |
Pinz Capital Management, LP | 15,600 | $12,000 | 0.01% |
D. E. Shaw & Co., Inc. | 8,051,858 | $6,281,000 | 0.01% |